Institutional investors purchased a net $3.2 million shares of INO during the quarter ended March 2016, and now own 27.86% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FOX RUN MANAGEMENT LLC Bought 27.0 Thousand shares of Inovio Pharmaceuticals In...